Who we are

The AAC is a unique partnership chaired by Lord Darzi. It brings together leaders from across the healthcare landscape. This includes government, NHS, industry and patient representatives. Their aim is to drive the uptake and adoption of innovation within the health and care system. They'll identify and support the best new innovations that will be most promising for patients.

Member organisations include:

  • Academic Health Science Networks
  • Association of British HealthTech Industries
  • Association of British Pharmaceutical Industries
  • Association of Medical Research Charities
  • BioIndustry Association
  • Department for Business, Energy and Industrial Strategy
  • Department of Health and Social Care
  • Medicines and Healthcare products Regulatory Agency
  • National Institute for Health and Care Excellence
  • National Voices
  • NHS England
  • NHS Improvement
  • A representative from the diagnostics industry
  • A representative from the digital health industry.

What's our role?

We aim to:

  • drive the uptake and adoption of innovation in the NHS
  • identify and support innovations that will deliver the most benefits for patients
  • streamline existing activities for high potential, innovative products
  • develop new and different ways of working to speed up processes.

We're boosting and strengthening the AAC. The new AAC will act as the umbrella organisation for UK health innovation, be the front door to support for innovators and will set the strategy for a more effective health innovation ecosystem. 

How are we governed?

The AAC is made up of the board, steering group and secretariat. 

AAC board

This comprises the most senior representatives from the AAC partner organisations, the health technology industry and clinical, research and patient representatives. The board is accountable to the Minister for Health.

The board decides which products we'll support and oversees the acceleration progress of the designated products.

AAC steering group

This is made up of senior level representatives from the AHSNs, MHRA, NHS England, NHS Improvement, National Institute  for Health and Care Excellence, National Institute for Health Research, Department of Health and Social Care and Department for Business, Energy and Industrial Strategy. They identify and shortlist products, and make recommendations to the board on which products should receive support. They also agree to activities needed to accelerate the progress of those products.

AAC secretariat

The secretariat is hosted by NICE and acts as a hub to coordinate and support the activities of the AAC board and steering group. They design and maintain the processes and methods that enable the board and steering group to deliver their respective responsibilities. This includes identifying strategically important products and managing acceleration plans. 


The new AAC will be led by the existing senior board, under the chairmanship of Lord Darzi. To meet our new responsibilities, a new dedicated delivery unit will be established within NHS England and NHS Improvement to support Lord Darzi and the board in delivering their vision.

The AAC will ensure an effective and joined up approach to the NHS collaboration strand of the Life Sciences Industrial Strategy.